Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Tekmira Pharmaceuticals Corporation”

14 pharma patents match "Tekmira Pharmaceuticals Corporation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 14
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 14 pharmaceutical patents matching "Tekmira Pharmaceuticals Corporation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

14 results for “Tekmira Pharmaceuticals Corporation” · 30,257 patents in full index Clear search

  1. US 9801874

    Method for the preparation of liposome encapsulated vincristine for therapeutic use

    Tekmira Pharmaceuticals Corporation · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  2. US 9345780

    Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

    Tekmira Pharmaceuticals Corporation · Granted May 24, 2016 · Expires May 19, 2036

    granted
  3. US 9220683

    Lipids and compositions for the delivery of therapeutics

    Tekmira Pharmaceuticals Corporation · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  4. US 9186325

    Lipids and compositions for the delivery of therapeutics

    Tekmira Pharmaceuticals Corporation · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  5. US 9139554

    Amino lipids and methods for the delivery of nucleic acids

    Tekmira Pharmaceuticals Corporation · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted
  6. US 9051567

    Methods for increasing efficacy of lipid formulated siRNA

    Tekmira Pharmaceuticals Corporation · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  7. US 8999351

    Lipids and compositions for the delivery of therapeutics

    Tekmira Pharmaceuticals Corporation · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  8. US 8883202

    Lipid compositions

    Tekmira Pharmaceuticals Corporation · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted
  9. US 8802644

    Lipid formulation

    Tekmira Pharmaceuticals Corporation · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  10. US 8722082

    Lipids and compositions for the delivery of therapeutics

    Tekmira Pharmaceuticals Corporation · Granted May 13, 2014 · Expires May 8, 2034

    granted
  11. US 8642076

    Lipid containing formulations

    Tekmira Pharmaceuticals Corporation · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted
  12. US 8575123

    Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

    Tekmira Pharmaceuticals Corporation · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted
  13. US 7811602

    Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof

    Tekmira Pharmaceuticals Corporation · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  14. US 7244448

    Liposomal antineoplastic drugs and uses thereof

    Tekmira Pharmaceuticals Corporation · Granted Jul 17, 2007 · Expires Jul 12, 2027

    granted